Detalles de la búsqueda
1.
A Randomized Phase II Study of Sequential Eribulin Versus Paclitaxel Followed by FAC/FEC as Neoadjuvant Therapy in Patients with Operable HER2-Negative Breast Cancer.
Oncologist
; 26(2): e230-e240, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33140515
2.
Targeting chemotherapy resistance in mesenchymal triple-negative breast cancer: a phase II trial of neoadjuvant angiogenic and mTOR inhibition with chemotherapy.
Invest New Drugs
; 41(3): 391-401, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37043123
3.
Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancer.
Breast Cancer Res Treat
; 158(1): 67-77, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27287781
4.
Phase I Study of Everolimus, Letrozole, and Trastuzumab in Patients with Hormone Receptor-positive Metastatic Breast Cancer or Other Solid Tumors.
Clin Cancer Res
; 27(5): 1247-1255, 2021 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33115815
5.
Rapid Breast Cancer Disease Progression Following Cyclin Dependent Kinase 4 and 6 Inhibitor Discontinuation.
J Cancer
; 8(11): 2004-2009, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28819400
6.
Targeting the PI3K/AKT/mTOR Pathway for the Treatment of Mesenchymal Triple-Negative Breast Cancer: Evidence From a Phase 1 Trial of mTOR Inhibition in Combination With Liposomal Doxorubicin and Bevacizumab.
JAMA Oncol
; 3(4): 509-515, 2017 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27893038
7.
TBCRC-010: Phase I/II Study of Dasatinib in Combination with Zoledronic Acid for the Treatment of Breast Cancer Bone Metastasis.
Clin Cancer Res
; 22(23): 5706-5712, 2016 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27166393
8.
Phase II Randomized Study of Ixabepilone Versus Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2-Negative Breast Cancer.
Clin Breast Cancer
; 15(5): 325-31, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25913905
9.
Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor-positive metastatic breast cancer.
Cancer Chemother Pharmacol
; 71(1): 63-72, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23053261
Resultados
1 -
9
de 9
1
Próxima >
>>